Pfeffer LM - Search Results

1

Chromenes: potential new chemotherapeutic agents for cancer.

Patil SA, Patil R, Pfeffer LM, Miller DD. Patil SA, et al. Among authors: pfeffer lm. Future Med Chem. 2013 Sep;5(14):1647-60. doi: 10.4155/fmc.13.126. Future Med Chem. 2013. PMID: 24047270 Review.

2

Interferon-resistant Daudi cell line with a Stat2 defect is resistant to apoptosis induced by chemotherapeutic agents.

Du Z, Fan M, Kim JG, Eckerle D, Lothstein L, Wei L, Pfeffer LM. Du Z, et al. Among authors: pfeffer lm. J Biol Chem. 2009 Oct 9;284(41):27808-27815. doi: 10.1074/jbc.M109.028324. Epub 2009 Aug 17. J Biol Chem. 2009. PMID: 19687011 Free PMC article.

3

Novel approaches to glioma drug design and drug screening.

Patil SA, Hosni-Ahmed A, Jones TS, Patil R, Pfeffer LM, Miller DD. Patil SA, et al. Among authors: pfeffer lm. Expert Opin Drug Discov. 2013 Sep;8(9):1135-51. doi: 10.1517/17460441.2013.807248. Epub 2013 Jun 6. Expert Opin Drug Discov. 2013. PMID: 23738794 Review.

4

Identification of imidazoquinoline derivatives as potent antiglioma agents.

Patil SA, Pfeffer SR, Seibel WL, Pfeffer LM, Miller DD. Patil SA, et al. Among authors: pfeffer sr, pfeffer lm. Med Chem. 2015;11(4):400-6. doi: 10.2174/1573406410666140914162701. Med Chem. 2015. PMID: 25219925

5

EDL-360: A Potential Novel Antiglioma Agent.

Hosni-Ahmed A, Sims M, Jones TS, Patil R, Patil S, Abdelsamed H, Yates CR, Miller DD, Pfeffer LM. Hosni-Ahmed A, et al. Among authors: pfeffer lm. J Cancer Sci Ther. 2014 Sep 25;6(9):370-377. doi: 10.4172/1948-5956.1000295. J Cancer Sci Ther. 2014. PMID: 25574358 Free PMC article.

6

Design, Synthesis and Biological Evaluation of Novel 5H-Chromenopyridines as Potential Anti-Cancer Agents.

Banerjee S, Wang J, Pfeffer S, Ma D, Pfeffer LM, Patil SA, Li W, Miller DD. Banerjee S, et al. Among authors: pfeffer s, pfeffer lm. Molecules. 2015 Sep 17;20(9):17152-65. doi: 10.3390/molecules200917152. Molecules. 2015. PMID: 26393554 Free PMC article.

7

Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer.

Ponnusamy S, He Y, Hwang DJ, Thiyagarajan T, Houtman R, Bocharova V, Sumpter BG, Fernandez E, Johnson D, Du Z, Pfeffer LM, Getzenberg RH, McEwan IJ, Miller DD, Narayanan R. Ponnusamy S, et al. Among authors: pfeffer lm. Clin Cancer Res. 2019 Nov 15;25(22):6764-6780. doi: 10.1158/1078-0432.CCR-19-1458. Epub 2019 Sep 3. Clin Cancer Res. 2019. PMID: 31481513

8

Brahma-Related Gene-1 (BRG1) promotes the malignant phenotype of glioblastoma cells.

Wang Y, Yang CH, Schultz AP, Sims MM, Miller DD, Pfeffer LM. Wang Y, et al. Among authors: pfeffer lm. J Cell Mol Med. 2021 Mar;25(6):2956-2966. doi: 10.1111/jcmm.16330. Epub 2021 Feb 2. J Cell Mol Med. 2021. PMID: 33528916 Free PMC article.

9

Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma.

Yang C, Wang Y, Sims MM, He Y, Miller DD, Pfeffer LM. Yang C, et al. Among authors: pfeffer lm. Pharmaceuticals (Basel). 2021 Sep 6;14(9):904. doi: 10.3390/ph14090904. Pharmaceuticals (Basel). 2021. PMID: 34577604 Free PMC article.

10

Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells.

He Y, Yang C, Wang Y, Sacher JR, Sims MM, Pfeffer LM, Miller DD. He Y, et al. Among authors: pfeffer lm. Bioorg Med Chem. 2022 Jan 1;53:116533. doi: 10.1016/j.bmc.2021.116533. Epub 2021 Nov 27. Bioorg Med Chem. 2022. PMID: 34863065

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page